Literature DB >> 20109534

Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study.

A Jucaite1, H Forssberg, P Karlsson, C Halldin, L Farde.   

Abstract

Age-dependent decrease in dopamine receptor density throughout adulthood is well described, meanwhile less is known about development of dopamine system in humans and in vivo it has not been investigated. We examined dopamine D1 receptor (D1DR) binding in the cerebral cortex and striatum of 12 adolescents (mean age 13.5+/-1.8 years) and 18 young adults (25+/-2.3 years) using positron emission tomography (PET) and radioligand [(11)C]SCH23390. Over the age span of 10-30 years [(11)C]SCH23390 binding (binding potential, BP) declined in all brain regions. The rate of BP decline was age-segment and brain region dependent. Most pronounced decline in BP was observed in the cortical regions during adolescence (mean BP in adults lower by 14-26% as compared to adolescents, P<0.0001). Significantly slower rate of decline in BP was observed in two cortical regions (orbitofrontal and posterior cingulate cortices) and striatal regions. The present PET-study provides new evidence on the development of D1DR in humans in vivo which is of critical importance for understanding of the biology of neurodevelopmental disorders. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109534     DOI: 10.1016/j.neuroscience.2010.01.034

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  20 in total

1.  Adolescent binge-like alcohol alters sensitivity to acute alcohol effects on dopamine release in the nucleus accumbens of adult rats.

Authors:  Tatiana A Shnitko; Linda P Spear; Donita L Robinson
Journal:  Psychopharmacology (Berl)       Date:  2016-02       Impact factor: 4.530

Review 2.  Neurobiology of adolescent substance use and addictive behaviors: treatment implications.

Authors:  Christopher J Hammond; Linda C Mayes; Marc N Potenza
Journal:  Adolesc Med State Art Rev       Date:  2014-04

Review 3.  Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.

Authors:  Sarah W Yip; Marc N Potenza
Journal:  Clin Psychol Rev       Date:  2016-11-09

4.  Alterations in adult behavioral responses to cocaine and dopamine transporters following juvenile exposure to methamphetamine.

Authors:  Lisa McFadden; Bryan K Yamamoto; Leslie Matuszewich
Journal:  Behav Brain Res       Date:  2010-09-09       Impact factor: 3.332

5.  Schizophrenic: forever young?

Authors:  Benedetta Frida Baldi; Christine Hoyer; Nicolas Le Novère
Journal:  Genome Med       Date:  2010-05-18       Impact factor: 11.117

6.  Functional connectivity of substantia nigra and ventral tegmental area: maturation during adolescence and effects of ADHD.

Authors:  Dardo Tomasi; Nora D Volkow
Journal:  Cereb Cortex       Date:  2012-12-12       Impact factor: 5.357

Review 7.  Adolescent brain development and the risk for alcohol and other drug problems.

Authors:  Sunita Bava; Susan F Tapert
Journal:  Neuropsychol Rev       Date:  2010-10-19       Impact factor: 7.444

8.  Ageing diminishes the modulation of human brain responses to visual food cues by meal ingestion.

Authors:  Y S Cheah; S Lee; G Ashoor; Y Nathan; L J Reed; F O Zelaya; M J Brammer; S A Amiel
Journal:  Int J Obes (Lond)       Date:  2013-12-16       Impact factor: 5.095

9.  Developmental changes in human dopamine neurotransmission: cortical receptors and terminators.

Authors:  Debora A Rothmond; Cynthia S Weickert; Maree J Webster
Journal:  BMC Neurosci       Date:  2012-02-15       Impact factor: 3.288

10.  Dopamine D1, D2, D3 receptors, vesicular monoamine transporter type-2 (VMAT2) and dopamine transporter (DAT) densities in aged human brain.

Authors:  Jianjun Sun; Jinbin Xu; Nigel J Cairns; Joel S Perlmutter; Robert H Mach
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.